The effect of Diamicron® on the secretion and action of insulin
- 31 December 1991
- journal article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 14, S47-S51
- https://doi.org/10.1016/0168-8227(91)90007-z
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Gliclazide therapy is associated with potentiation of postbinding insulin action in obese, non-insulin-dependent diabetic subjectsDiabetes, 1985
- Assessment of Insulin Sensitivityin Vivo*Endocrine Reviews, 1985
- Pathophysiology of Insulin Secretion in Non-insulin-dependent Diabetes MellitusDiabetes Care, 1984
- Hepatic and peripheral insulin resistance: A common feature of Type 2 (non-insulin-dependent) and Type 1 (insulin-dependent) diabetes mellitusDiabetologia, 1982
- Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitusDiabetes, 1981
- Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose.Journal of Clinical Investigation, 1981
- Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1981
- Insulin secretion in diabetes mellitusThe American Journal of Medicine, 1981
- Effets “in vitro” du gliclazide, nouvel agent hypoglycemiant, sur les plaquettes humaines normalesThrombosis Research, 1974
- A Simple Method for the Determination of Serum Free Insulin Levels in Insulin-treated PatientsDiabetes, 1973